Equilis Prequenza Te (equine influenza-virus strains: A/equine-2/South...) - QI05AL01
Updated on site: 09-Feb-2018
|Naziv lijeka:||Equilis Prequenza Te|
|Tvar:||equine influenza-virus strains: A/equine-2/South Africa/4/03, A/equine-2/Newmarket/2/93, tetanus toxoid|
|Proizvođač:||Intervet International BV|
Equilis Prequenza Te
Equine influenza and tetanus vaccine
This document is a summary of the European Public Assessment Report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.
This document cannot replace a
What is Equilis Prequenza Te?
Equilis Prequenza Te is a vaccine for use in horses. It contains inactivated (killed) whole virus of two equine influenza (flu) strains
What is Equilis Prequenza Te used for?
Equilis Prequenza Te is used to vaccinate horses from six months of age against equine influenza and tetanus. The vaccine reduces the signs of equine influenza and the excretion (shedding) of the virus after infection. Equine influenza is a highly contagious disease that is very common in horses but that rarely causes death.
The vaccine also stimulates protection against tetanus to prevent mortality. Tetanus is an acute, often fatal disease caused by the toxin (poison) produced by the bacterium Clostridium tetani. The disease, which usually originates from contaminated wounds, is characterised by overall rigidity (stiffness) and convulsive spasms of the muscles. Horses are very susceptible to tetanus.